American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways
Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial.
Gespeichert in:
| Autor*in: |
Dell’Osso, Bernardo [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis - Heidari, Somaye-Sadat ELSEVIER, 2021, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:188 ; year:2015 ; day:1 ; month:12 ; pages:257-262 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jad.2015.09.001 |
|---|
| Katalog-ID: |
ELV012820512 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV012820512 | ||
| 003 | DE-627 | ||
| 005 | 20230623102024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jad.2015.09.001 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015004000003.pica |
| 035 | |a (DE-627)ELV012820512 | ||
| 035 | |a (ELSEVIER)S0165-0327(15)30447-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Dell’Osso, Bernardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways |
| 264 | 1 | |c 2015 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. | ||
| 650 | 7 | |a Childhood onset |2 Elsevier | |
| 650 | 7 | |a Comorbidity |2 Elsevier | |
| 650 | 7 | |a Suicidality |2 Elsevier | |
| 650 | 7 | |a Bipolar I disorder (BDI) |2 Elsevier | |
| 650 | 7 | |a Pharmacotherapy |2 Elsevier | |
| 650 | 7 | |a Depression |2 Elsevier | |
| 650 | 7 | |a Bipolar II disorder (BDII) |2 Elsevier | |
| 650 | 7 | |a Family history |2 Elsevier | |
| 700 | 1 | |a Holtzman, Jessica N. |4 oth | |
| 700 | 1 | |a Goffin, Kathryn C. |4 oth | |
| 700 | 1 | |a Portillo, Natalie |4 oth | |
| 700 | 1 | |a Hooshmand, Farnaz |4 oth | |
| 700 | 1 | |a Miller, Shefali |4 oth | |
| 700 | 1 | |a Dore, Jennifer |4 oth | |
| 700 | 1 | |a Wang, Po W. |4 oth | |
| 700 | 1 | |a Hill, Shelley J. |4 oth | |
| 700 | 1 | |a Ketter, Terence A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Heidari, Somaye-Sadat ELSEVIER |t Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV000041335 |
| 773 | 1 | 8 | |g volume:188 |g year:2015 |g day:1 |g month:12 |g pages:257-262 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jad.2015.09.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 188 |j 2015 |b 1 |c 1201 |h 257-262 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
b d bd |
|---|---|
| matchkey_str |
dellossobernardoholtzmanjessicangoffinka:2015----:mrcnetaylnceerdioaidsrecmaetbplrdsremrsvrimlil |
| hierarchy_sort_str |
2015 |
| publishDate |
2015 |
| allfields |
10.1016/j.jad.2015.09.001 doi GBVA2015004000003.pica (DE-627)ELV012820512 (ELSEVIER)S0165-0327(15)30447-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Dell’Osso, Bernardo verfasserin aut American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history Elsevier Holtzman, Jessica N. oth Goffin, Kathryn C. oth Portillo, Natalie oth Hooshmand, Farnaz oth Miller, Shefali oth Dore, Jennifer oth Wang, Po W. oth Hill, Shelley J. oth Ketter, Terence A. oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 https://doi.org/10.1016/j.jad.2015.09.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 188 2015 1 1201 257-262 6 045F 610 |
| spelling |
10.1016/j.jad.2015.09.001 doi GBVA2015004000003.pica (DE-627)ELV012820512 (ELSEVIER)S0165-0327(15)30447-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Dell’Osso, Bernardo verfasserin aut American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history Elsevier Holtzman, Jessica N. oth Goffin, Kathryn C. oth Portillo, Natalie oth Hooshmand, Farnaz oth Miller, Shefali oth Dore, Jennifer oth Wang, Po W. oth Hill, Shelley J. oth Ketter, Terence A. oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 https://doi.org/10.1016/j.jad.2015.09.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 188 2015 1 1201 257-262 6 045F 610 |
| allfields_unstemmed |
10.1016/j.jad.2015.09.001 doi GBVA2015004000003.pica (DE-627)ELV012820512 (ELSEVIER)S0165-0327(15)30447-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Dell’Osso, Bernardo verfasserin aut American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history Elsevier Holtzman, Jessica N. oth Goffin, Kathryn C. oth Portillo, Natalie oth Hooshmand, Farnaz oth Miller, Shefali oth Dore, Jennifer oth Wang, Po W. oth Hill, Shelley J. oth Ketter, Terence A. oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 https://doi.org/10.1016/j.jad.2015.09.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 188 2015 1 1201 257-262 6 045F 610 |
| allfieldsGer |
10.1016/j.jad.2015.09.001 doi GBVA2015004000003.pica (DE-627)ELV012820512 (ELSEVIER)S0165-0327(15)30447-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Dell’Osso, Bernardo verfasserin aut American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history Elsevier Holtzman, Jessica N. oth Goffin, Kathryn C. oth Portillo, Natalie oth Hooshmand, Farnaz oth Miller, Shefali oth Dore, Jennifer oth Wang, Po W. oth Hill, Shelley J. oth Ketter, Terence A. oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 https://doi.org/10.1016/j.jad.2015.09.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 188 2015 1 1201 257-262 6 045F 610 |
| allfieldsSound |
10.1016/j.jad.2015.09.001 doi GBVA2015004000003.pica (DE-627)ELV012820512 (ELSEVIER)S0165-0327(15)30447-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Dell’Osso, Bernardo verfasserin aut American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history Elsevier Holtzman, Jessica N. oth Goffin, Kathryn C. oth Portillo, Natalie oth Hooshmand, Farnaz oth Miller, Shefali oth Dore, Jennifer oth Wang, Po W. oth Hill, Shelley J. oth Ketter, Terence A. oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 https://doi.org/10.1016/j.jad.2015.09.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 188 2015 1 1201 257-262 6 045F 610 |
| language |
English |
| source |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 |
| sourceStr |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:188 year:2015 day:1 month:12 pages:257-262 extent:6 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Childhood onset Comorbidity Suicidality Bipolar I disorder (BDI) Pharmacotherapy Depression Bipolar II disorder (BDII) Family history |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| authorswithroles_txt_mv |
Dell’Osso, Bernardo @@aut@@ Holtzman, Jessica N. @@oth@@ Goffin, Kathryn C. @@oth@@ Portillo, Natalie @@oth@@ Hooshmand, Farnaz @@oth@@ Miller, Shefali @@oth@@ Dore, Jennifer @@oth@@ Wang, Po W. @@oth@@ Hill, Shelley J. @@oth@@ Ketter, Terence A. @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000041335 |
| dewey-sort |
3610 |
| id |
ELV012820512 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012820512</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2015.09.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012820512</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(15)30447-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dell’Osso, Bernardo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Childhood onset</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Comorbidity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Suicidality</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bipolar I disorder (BDI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bipolar II disorder (BDII)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Family history</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Holtzman, Jessica N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goffin, Kathryn C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Portillo, Natalie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hooshmand, Farnaz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miller, Shefali</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dore, Jennifer</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Po W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hill, Shelley J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ketter, Terence A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:188</subfield><subfield code="g">year:2015</subfield><subfield code="g">day:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:257-262</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2015.09.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">188</subfield><subfield code="j">2015</subfield><subfield code="b">1</subfield><subfield code="c">1201</subfield><subfield code="h">257-262</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Dell’Osso, Bernardo |
| spellingShingle |
Dell’Osso, Bernardo ddc 610 ddc 570 Elsevier Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways |
| authorStr |
Dell’Osso, Bernardo |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000041335 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 540 VZ American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history Elsevier |
| topic |
ddc 610 ddc 570 Elsevier Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history |
| topic_unstemmed |
ddc 610 ddc 570 Elsevier Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history |
| topic_browse |
ddc 610 ddc 570 Elsevier Childhood onset Elsevier Comorbidity Elsevier Suicidality Elsevier Bipolar I disorder (BDI) Elsevier Pharmacotherapy Elsevier Depression Elsevier Bipolar II disorder (BDII) Elsevier Family history |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j n h jn jnh k c g kc kcg n p np f h fh s m sm j d jd p w w pw pww s j h sj sjh t a k ta tak |
| hierarchy_parent_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| hierarchy_parent_id |
ELV000041335 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000041335 |
| title |
American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways |
| ctrlnum |
(DE-627)ELV012820512 (ELSEVIER)S0165-0327(15)30447-X |
| title_full |
American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways |
| author_sort |
Dell’Osso, Bernardo |
| journal |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| journalStr |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
257 |
| author_browse |
Dell’Osso, Bernardo |
| container_volume |
188 |
| physical |
6 |
| class |
610 610 DE-600 570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Dell’Osso, Bernardo |
| doi_str_mv |
10.1016/j.jad.2015.09.001 |
| dewey-full |
610 570 540 |
| title_sort |
american tertiary clinic-referred bipolar ii disorder compared to bipolar i disorder: more severe in multiple ways, but less severe in a few other ways |
| title_auth |
American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways |
| abstract |
Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. |
| abstractGer |
Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. |
| abstract_unstemmed |
Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways |
| url |
https://doi.org/10.1016/j.jad.2015.09.001 |
| remote_bool |
true |
| author2 |
Holtzman, Jessica N. Goffin, Kathryn C. Portillo, Natalie Hooshmand, Farnaz Miller, Shefali Dore, Jennifer Wang, Po W. Hill, Shelley J. Ketter, Terence A. |
| author2Str |
Holtzman, Jessica N. Goffin, Kathryn C. Portillo, Natalie Hooshmand, Farnaz Miller, Shefali Dore, Jennifer Wang, Po W. Hill, Shelley J. Ketter, Terence A. |
| ppnlink |
ELV000041335 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jad.2015.09.001 |
| up_date |
2024-07-06T17:16:20.211Z |
| _version_ |
1803850801704075264 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012820512</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2015.09.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012820512</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(15)30447-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dell’Osso, Bernardo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Prevalence and relative severity of bipolar II disorder (BDII) vs. bipolar I disorder (BDI) are controversial.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Childhood onset</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Comorbidity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Suicidality</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bipolar I disorder (BDI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bipolar II disorder (BDII)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Family history</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Holtzman, Jessica N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goffin, Kathryn C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Portillo, Natalie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hooshmand, Farnaz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miller, Shefali</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dore, Jennifer</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Po W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hill, Shelley J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ketter, Terence A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:188</subfield><subfield code="g">year:2015</subfield><subfield code="g">day:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:257-262</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2015.09.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">188</subfield><subfield code="j">2015</subfield><subfield code="b">1</subfield><subfield code="c">1201</subfield><subfield code="h">257-262</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3980913 |